Preventive Strategies and Screening Protocols for Early Detection of Breast Cancer

Abstract

Breast cancer is a critical global health issue, with around 2.3 million new cases annually. Risk factors include genetic predispositions, hormonal influences, and lifestyle choices. Preventive measures have evolved, particularly for women with BRCA1/2 mutations, though their uptake varies. Recent guidelines aim to expand testing criteria, enabling earlier identification of high-risk individuals. While treatments have advanced, especially for early-stage cancers through multimodal approaches, metastatic breast cancer remains challenging to cure. The World Health Organization emphasizes the importance of early diagnosis and screening, particularly in low- and middle-income countries where late-stage diagnoses are more common. Ongoing research focuses on preventive strategies such as diet, exercise, and chemoprevention. Innovative diagnostic tools and targeted therapies, including nanoparticle-based methods, show promise for earlier detection and personalized treatment. Enhancing both preventive measures and management strategies is crucial for improving outcomes and reducing the global burden of breast cancer. Addressing these factors comprehensively is essential for effective breast cancer control worldwide.